Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.18 USD | 0.00% | -3.28% | +12.38% |
May. 07 | Transcript : Aclaris Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
May. 07 | Earnings Flash (ACRS) ACLARIS THERAPEUTICS Reports Q1 Revenue $2.4M, vs. Street Est of $2M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.38% | 84.09M | |
+29.77% | 49.18B | |
+1.00% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.68% | 26.09B | |
-22.99% | 18.71B | |
+8.22% | 13.26B | |
+32.41% | 12.32B | |
-1.62% | 11.99B |
- Stock Market
- Equities
- ACRS Stock
- News Aclaris Therapeutics, Inc.
- BTIG Research Adjusts Aclaris Therapeutics Price Target to $29 From $32, Maintains Buy Rating